AroCell AB

ST:AROC Sweden Diagnostics & Research
Market Cap
$11.09 Million
Skr124.39 Million SEK
Market Cap Rank
#30154 Global
#450 in Sweden
Share Price
Skr0.54
Change (1 day)
+1.12%
52-Week Range
Skr0.49 - Skr0.60
All Time High
Skr15.05
About

AroCell AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cell; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. The company was formerly known as Xi Bao Research AB… Read more

AroCell AB (AROC) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of March 2025: -0.010x

Based on the latest financial reports, AroCell AB (AROC) has a cash flow conversion efficiency ratio of -0.010x as of March 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.11 Million) by net assets (Skr108.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

AroCell AB - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how AroCell AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

AroCell AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AroCell AB ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for AroCell AB (2011–2024)

The table below shows the annual cash flow conversion efficiency of AroCell AB from 2011 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr121.20 Million Skr-2.36 Million -0.019x +76.30%
2023-12-31 Skr163.65 Million Skr-13.44 Million -0.082x -33.52%
2022-12-31 Skr222.69 Million Skr-13.69 Million -0.061x +52.59%
2021-12-31 Skr217.45 Million Skr-28.21 Million -0.130x +61.39%
2020-12-31 Skr56.26 Million Skr-18.90 Million -0.336x -79.44%
2019-12-31 Skr80.41 Million Skr-15.06 Million -0.187x +37.79%
2018-12-31 Skr54.51 Million Skr-16.41 Million -0.301x +7.78%
2017-12-31 Skr46.68 Million Skr-15.24 Million -0.326x -188.96%
2016-12-31 Skr63.46 Million Skr-7.17 Million -0.113x +10.05%
2015-12-31 Skr72.69 Million Skr-9.13 Million -0.126x +76.77%
2011-12-31 Skr4.80 Million Skr-2.59 Million -0.541x --